Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection

NCT05276700 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05276700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05276700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2022
Completion date
March 31, 2024
Enrollment
170 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcv, renal injury